SUBCLINICAL DISEASE AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR-DISEASE

被引:247
作者
KULLER, LH
SHEMANSKI, L
PSATY, BM
BORHANI, NO
GARDIN, J
HAAN, MN
OLEARY, DH
SAVAGE, PJ
TELL, GS
TRACY, R
机构
[1] UNIV WASHINGTON, SCH MED, SEATTLE, WA USA
[2] UNIV CALIF IRVINE, DIV CARDIOL, DAVIS, CA USA
[3] UNIV CALIF SACRAMENTO, DEPT INTERNAL MED, SACRAMENTO, CA USA
[4] GEISINGER MED CTR, DIV RADIOL, DANVILLE, PA 17822 USA
[5] NHLBI, DECA, BETHESDA, MD USA
[6] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT PUBL HLTH SCI, WINSTON SALEM, NC 27103 USA
[7] UNIV VERMONT, DEPT PATHOL BIOCHEM, COLCHESTER, VT USA
关键词
CARDIOVASCULAR DISEASES; MORBIDITY; MORTALITY; RISK FACTORS; AGING;
D O I
10.1161/01.CIR.92.4.720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The primary aim of the present study was to determine the relation between measures of subclinical cardiovascular disease and the incidence of clinical cardiovascular disease among 5201 adults 65 years of age or older who were participating in the Cardiovascular Health Study. Methods and Results A new method of classifying subclinical disease at baseline examination in the Cardiovascular Health Study included measures of ankle-brachial blood pressure, carotid artery stenosis and wall thickness, ECG and echocardiographic abnormalities, and positive response to the Rose Angina and Claudication Questionnaire. Participants were followed for an average of 2.39 years (maximum, 3 years). For participants without evidence of clinical cardiovascular disease at baseline, the presence of subclinical disease compared with no subclinical disease was associated with a significant increased risk of incident total coronary heart disease including CHD deaths and nonfatal MI and angina pectoris for both men and women. For individuals with subclinical disease, the increased risk of total coronary heart disease was 2.0 for men and 2.5 for women, and the increased risk of total mortality was 2.9 for men and 1.7 for women. The increased risk changed little after adjustment for other risk factors, including lipoprotein levels, blood pressure, smoking, and diabetes. Conclusions The measurement of subclinical disease provides an approach for identifying high-risk older individuals who may be candidates for more active intervention to prevent clinical disease.
引用
收藏
页码:720 / 726
页数:7
相关论文
共 46 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]  
[Anonymous], 1991, JAMA, V265, P3255
[3]  
[Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002
[4]   45-MONTH FOLLOW-UP OF EXTRACRANIAL CAROTID ARTERIAL-DISEASE FOR NEW CORONARY EVENTS IN ELDERLY PATIENTS [J].
ARONOW, WS ;
SCHOENFELD, MR .
CORONARY ARTERY DISEASE, 1992, 3 (03) :249-251
[5]  
AUTRET A, 1987, LANCET, V1, P888
[6]   EVALUATION OF THE ASSOCIATIONS BETWEEN CAROTID-ARTERY ATHEROSCLEROSIS AND CORONARY-ARTERY STENOSIS - A CASE-CONTROL STUDY [J].
CRAVEN, TE ;
RYU, JE ;
ESPELAND, MA ;
KAHL, FR ;
MCKINNEY, WM ;
TOOLE, JF ;
MCMAHAN, MR ;
THOMPSON, CJ ;
HEISS, G ;
CROUSE, JR .
CIRCULATION, 1990, 82 (04) :1230-1242
[7]   MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE [J].
CRIQUI, MH ;
LANGER, RD ;
FRONEK, A ;
FEIGELSON, HS ;
KLAUBER, MR ;
MCCANN, TJ ;
BROWNER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) :381-386
[8]   CHOLESTEROL, PRIMARY AND SECONDARY PREVENTION, AND ALL-CAUSE MORTALITY [J].
CRIQUI, MH .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) :973-976
[9]  
DAVIES MJ, 1985, BRIT HEART J, V53, P363
[10]   ROLE OF PRECLINICAL CARDIOVASCULAR-DISEASE IN THE EVOLUTION FROM RISK FACTOR EXPOSURE TO DEVELOPMENT OF MORBID EVENTS [J].
DEVEREUX, RB ;
ALDERMAN, MH .
CIRCULATION, 1993, 88 (04) :1444-1455